Search EPC
EDGEWELL PERSONAL CARE Co
NYSE · CIK 1096752
Last close26.97
Daily change+0.30 (1.12%)
10 Years gain-61.43%
Dividends TTM0.6 (+0.00%)
Dividend yield2.25%
Fundamental Analysis
EPC · STANDARD
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations · Fiscal year end 0930
Fundamental
35.1Momentum
18.3Acceleration
24.4Confidence
92.0Annual Revenue18
Quarterly Revenue78
Annual CFO18
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth2.2 / 25
Quality14.3 / 25
Capital Efficiency1.8 / 20
Balance Sheet6.7 / 15
Shareholder Economics8.4 / 10
Forward Indicators0.0 / 5
Signals
FCF growthFree cash flow grew 3.4415%.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 3.3195%.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 6.3354 percentage points.
Low interest coverage · HIGHInterest coverage is 0.9482x.
ROIC declining · MEDIUMROIC declined by 3.2824 percentage points.
Key Metrics
Revenue Growth TTM-4.87%OK
Revenue CAGR 3Y0.79%OK
Gross Margin42%OK
Operating Margin3.35%OK
FCF Margin5.08%OK
FCF Growth3.44%OK
ROIC1.72%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO5.27xOK
Diluted Share Growth 1Y-3.32%OK
SBC / Revenue1.02%OK
SBC / FCF20.06%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Sep 30, 2025 | $2.22B | $924.90M | $96.60M | $118.40M | $41.40M | 41.6% | 4.34% | 1.86% | 3.32% | 47.6M |
| 2025 FY Sep 30, 2024 | $2.25B | $955.70M | $199.30M | -$231.00M | -$287.50M | 42.41% | 8.84% | -12.76% | 6.07% | 50.1M |
| 2025 FY Sep 30, 2023 | $2.25B | $940.80M | $227.00M | -$216.10M | -$265.60M | 41.78% | 10.08% | -11.8% | 6.55% | 51.8M |
| 2024 FY Sep 30, 2022 | $2.17B | $880.50M | $182.30M | $102.00M | $45.60M | 40.54% | 8.39% | 2.1% | 5.79% | 53.6M |
| 2023 FY Sep 30, 2021 | $2.09B | $951.20M | $239.90M | $229.00M | $172.20M | 45.57% | 11.49% | 8.25% | 8.2% | 55.2M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.07B | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-053128, 0001628280-26-006288 |
| Revenue Growth TTM | -4.87% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-053128, 0001628280-26-006288 |
| Revenue CAGR 3Y | 0.79% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-25-052765 |
| Revenue CAGR 5Y | 2.66% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-25-052765 |
| Gross Profit CAGR 3Y | 1.65% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-25-052765 |
| Operating Income Growth | -67.08% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001628280-26-053128, 0001628280-26-006288 |
| FCF Growth | 3.44% | FCF_current / FCF_prior_year - 1 | OK | 0001628280-26-053128, 0001628280-26-031376 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 42% | Gross Profit / Revenue | OK | 0001628280-26-053128, 0001628280-26-006288 |
| Operating Margin | 3.35% | Operating Income / Revenue | OK | 0001628280-26-053128, 0001628280-26-006288 |
| FCF Margin | 5.08% | (CFO - CapEx) / Revenue | OK | 0001628280-26-053128, 0001628280-26-031376 |
| ROIC | 1.72% | NOPAT / Average Invested Capital | OK | 0001628280-26-053128, 0001628280-26-006288 |
| Net Debt / CFO | 5.27x | Net Debt / CFO | OK | 0001628280-26-053128, 0001628280-26-031376 |
| Interest Coverage | 0.95x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 1.84x | Current Assets / Current Liabilities | OK | derived |